Targeted inhibition of menin promotes β‐catenin‐mediated GLP ‐1 expression and improves glucose tolerance in high‐fat diet‐induced obese mice
The FASEB Journal · 2025
DOI: 10.1096/fj.202402269rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xiaoru Cao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Diet, High-Fat, beta Catenin, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Glucagon‐like peptide‐1 (GLP‐1), derived from enteroendocrine cells, is a pivotal hormone crucial for blood glucose regulation. Menin, encoded by the MEN1 gene and known for its tumor suppressor role, is abundantly expressed in the intestine. Previous research has demonstrated that acute Men1 excision reverses preexisting glucose intolerance in high‐fat diet‐fed mice. However, its impact on GLP‐1 expression in enteroendocrine cells has not been investigated. In the present study, both the knockdown of Men1 and the administration of the MI‐463 menin inhibitor increased GLP‐1 expression in glucose‐stimulated STC‐1 cells. Additionally, administering MI‐463 to obese mice significantly elevated GLP‐1 levels in both ileal epithelial cells and serum. Mechanistically, menin inhibition enhanced the nuclear accumulation of β‐catenin, allowing it to bind TCF7L2, thereby increasing glucagon gene ( Gcg ) transcription. Furthermore, compared with control mice, mice with intestinal epithelial cell‐specific Men1 knockdown exhibited significant improvements in glucose tolerance under fat challenge, which was correlated with elevated GLP‐1 levels. These findings suggest that menin‐mediated regulation of GLP‐1 expression may be an important mechanism through which menin inhibiton alleviates type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Harbin Medical University, Harbin, China.
- Research Center for Pharmacoinformatics, College of Pharmacy, Harbin Medical University, Harbin, China.
- Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- National Health Commission Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
ORCID-Profile: Xiaoru Cao, Qian Zhang, Haiyue Meng, Chenghao Wang, Zhitao Guo, Yinghao Guo, Yakun Luo, Bin Sun, Jian Ma
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Cao, X., Yu, L., Zhang, Q., Cheng, Z., Meng, H., Wang, C., Guo, Z., Guo, Y., Xin, G., Wang, Y., Zhou, P., Luo, Y., Sun, B., & Ma, J. (2025). Targeted inhibition of menin promotes β‐catenin‐mediated GLP ‐1 expression and improves glucose tolerance in high‐fat diet‐induced obese mice. The FASEB Journal. https://doi.org/10.1096/fj.202402269rr
Vancouver
Cao X, Yu L, Zhang Q, Cheng Z, Meng H, Wang C, et al. Targeted inhibition of menin promotes β‐catenin‐mediated GLP ‐1 expression and improves glucose tolerance in high‐fat diet‐induced obese mice. The FASEB Journal. 2025. doi:10.1096/fj.202402269rr
BibTeX
@article{Cao2025,
author = {Cao, Xiaoru and Yu, Ling and Zhang, Qian and Cheng, Zhaosi and Meng, Haiyue and Wang, Chenghao and Guo, Zhitao and Guo, Yinghao and Xin, Guoshun and Wang, Yue and Zhou, Pingping and Luo, Yakun and Sun, Bin and Ma, Jian},
title = {Targeted inhibition of menin promotes β‐catenin‐mediated GLP ‐1 expression and improves glucose tolerance in high‐fat diet‐induced obese mice},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202402269rr}
}
EUVIMED